Clinical Trial

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-06-30; most recent amendment 2025-01-27.
Status change: Not Yet Recruiting → Recruiting 2021-10-13
Trial Details
NCT Number NCT04957511
Lead Sponsor Viome
Collaborators: AdventHealth
Conditions Gynecologic Cancer, Immunotherapy, Gut Microbiome
Enrollment 30 participants
Start Date 2021-06-29
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-01-29